Clinical Trials Browser

Phase 1/2 × Not yet recruiting × spartalizumab × Clear all

NCT07365592 2026-01-26

Neo-CD

Phase 1/2 Not yet recruiting

Gastrointestinal

Colorectal Neoplasms

NCT07245901 2025-11-24

Safety and Tolerability of a mRNA Vaccine Encoding Tumor-Specific Circular RNA Antigens in Combination With Anti-PD-1 Monoclonal Antibody in Patients With Advanced Solid Tumors

Phase 1/2 Not yet recruiting

Other solid neoplasm

Solid Tumor